Liver-expressed antimicrobial peptide-2 (LEAP-2), a ghrelin receptor antagonist, has been connected to obesity and liver fat buildup in adults, but pediatric data are limited. Here, GHSR is linked to obesity due to melanocortin 4 receptor deficiency.